To include your compound in the COVID-19 Resource Center, submit it here.

Proteomics company Seer launches with $36M

Counting nanoparticle pioneer Omid Farokhzad, Robert Langer and Biogen Inc. (NASDAQ:BIIB) vet Philip Ma among its founders, proteomic data company Seer Inc. (South San Francisco, Calif.) launched on Dec. 17 to develop liquid biopsy tests for early detection of multiple cancers and

Read the full 425 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers